Fortunens Totalentreprise ApS — Credit Rating and Financial Key Figures

CVR number: 39002825
Frederiksgade 11, 1265 København K
jns@xgxpharma.com
tel: 31427682

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Gross profit-17.85-15.65-12.64-11.16
Employee benefit expenses-0.30
EBIT- 720.84-17.85-15.95-12.64-11.16
Other financial income0.030.03
Other financial expenses-0.01-0.01-0.02-0.08-0.02
Pre-tax profit- 720.85-17.83-15.97-12.72-11.18
Net earnings- 720.85-17.83-15.97-12.72-11.18

Assets (kDKK)

2020
2021
2022
2023
2024
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current trade debtors52.2540.102.39
Current other receivables2.704.4314.9015.3814.62
Current deferred tax assets30.0330.0330.0330.03
Short term receivables total54.9574.5747.3245.4144.65
Cash and bank deposits0.510.05
Cash and cash equivalents0.510.05
Balance sheet total (assets)55.4674.5747.3245.4144.71

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital5.0040.0040.0040.0040.00
Retained earnings- 461.05-1 181.92-1 199.75-1 215.72-1 228.44
Profit of the financial year- 720.85-17.83-15.97-12.72-11.18
Shareholders equity total-1 176.90-1 159.75-1 175.72-1 188.44-1 199.62
Non-current owed to participating1 234.321 222.821 232.721 244.32
Non-current liabilities total1 234.321 222.821 232.721 244.32
Current loans from credit institutions0.221.13
Current owed to participating1 232.36
Current liabilities total1 232.360.221.13
Balance sheet total (liabilities)55.4674.5747.3245.4144.71
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.